GlassScriptPhysician profile
Jacob Kriegel
NPI 1871936286
$2,863.74
in general payments reported to CMS, 2019-2025
10 companies · $1,911 in 2025
The $1,911 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $115 · 2021: $110 · 2022: $275 · 2023: $130 · 2024: $164 · 2025: $1,911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,582 · Food and Beverage: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,581.66 |
| Food and Beverage | $623.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,087.47 | 2019-2025 | Mitris Resilia Mitral Valve |
| Artivion, INC. | $317.56 | 2024-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Photofix Decellularized Bovine Pericardium, Cryovalve Sg Pulmonary Human Heart Valve |
| Atricure, INC. | $187.25 | 2021-2022 | |
| Abiomed | $103.85 | 2023 | Impella |
| Baxter Healthcare | $50.70 | 2021-2022 | |
| Biom'Up France Sas | $26.63 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $26.17 | 2023 | Camzyos |
| Convatec INC. | $24.42 | 2021 | |
| Janssen Scientific Affairs, LLC | $20.06 | 2024 | Xarelto |
| Abbott Laboratories | $19.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Kriegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.